AWM
GILD icon

AE Wealth Management’s Gilead Sciences GILD Stock Holding History

AE Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,000
Closed -$3K – 1513
2020
Q4 		$3K Buy
+2,000
New +$121K ﹤0.01% 1352

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AE Wealth Management's GILD Position: Q1 2026 in Review

AE Wealth Management increased its Gilead Sciences (GILD) stake by 12% in Q1 2026, buying an estimated $940K and bringing the position to 65,053 shares worth $9.07M. The position accounts for 0.05% of the portfolio, ranked #305.

AE Wealth Management first reported a position in GILD in Q3 2017 and has held it in 35 quarters since. The position peaked at $29.7M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AE Wealth Management held 65,053 shares of Gilead Sciences worth $9.07M as of Q1 2026.
  • AE Wealth Management bought 6,710 Gilead Sciences shares in Q1 2026, an estimated $940K.
  • Gilead Sciences made up 0.05% of AE Wealth Management's portfolio in Q1 2026, its #305 holding.
  • AE Wealth Management first reported a position in Gilead Sciences in Q3 2017 and has held it in 35 quarters since.
  • AE Wealth Management's Gilead Sciences position peaked at $29.7M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.